Atlas Trials

Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Clinical trial NCT06065722 · UNKNOWN

Trial details

NCT number
NCT06065722
Sponsor
Simon Williamson Clinic
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy Induced Nausea and Vomiting
Start date
2023-09-09
Primary completion
2023-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.